//]]>

Renal Cell Carcinoma (Record no. 19857)

000 -LEADER
fixed length control field 03659nam a22004455i 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20140310150648.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 120925s2013 xxu| s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781627030625
978-1-62703-062-5
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC870-923.2
Classification number RC875-899.5
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.6
Edition number 23
264 #1 -
-- Totowa, NJ :
-- Humana Press :
-- Imprint: Humana Press,
-- 2013.
912 ## -
-- ZDB-2-SME
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Campbell, Steven C.
Relator term editor.
245 10 - IMMEDIATE SOURCE OF ACQUISITION NOTE
Title Renal Cell Carcinoma
Medium [electronic resource] :
Remainder of title Clinical Management /
Statement of responsibility, etc edited by Steven C. Campbell, Brian I. Rini.
300 ## - PHYSICAL DESCRIPTION
Extent XI, 362 p. 91 illus., 46 illus. in color.
Other physical details online resource.
440 1# - SERIES STATEMENT/ADDED ENTRY--TITLE
Title Current Clinical Urology
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Section I: Localized Disease -- 1.Etiology of RCC: Incidence, Demographics, and Environmental Factors -- 2.Pathology of Renal Cell Carcinoma -- 3.Familial Renal Cell Carinoma -- 4.Imaging of Renal Cell Carcinoma -- 5.Prognostic Factors for Localized Renal Cell Carcinoma -- Section II: Management of Localized RCC -- 6.Assessment of Oncologic Risk for Clinical Stage T1 Renal Tumors and the Emerging Role of Renal Mass Biopsy -- 7.Radical Nephrectomy for Localized Renal Tumors: Oncological and Renal Functional Considerations -- 8.Nephron-Sparing Surgery for Renal Cancer -- 9.Thermal Ablation -- 10.Active Surveillance of the Small Renal Mass -- Section III: Locally Advanced Disease -- 11.Locally Advanced Renal Cell Carcinoma -- 12.Neoadjuvant Targeted Therapy and Consolidative Surgery -- Section IV: Advanced Disease -- 13.Biology of RCC (VEGF, mTOR, immune aspects) -- 14.Prognostic Factors in Advanced Renal Cell Carcinoma -- 5.Integration of Surgery in Metastatic Renal Cancer -- 16.Immunotherapy for Renal Cell Carcinoma -- 17.Targeted Therapy: Vascular Endothelial Growth Factor (VEGF) -- 18.mTOR in Renal cell carcinoma -- 19.Palliative and Supportive Care for Renal Cancer.
520 ## - SUMMARY, ETC.
Summary, etc Renal Cell Carcinoma: Clinical Management provides a comprehensive, state-of-the art review of this field, and will serve as a valuable resource for clinicians, surgeons and researchers with an interest in kidney cancer. The volume reviews new data about risk factors for the disease, profiles the new staging system for renal cell carcinoma (RCC), highlights our current understanding of familial syndromes of RCC and their molecular genetics, and provides new perspectives about imaging of renal tumors. For localized disease, a greater appreciation of nephron-sparing approaches and the importance of preservation of renal function is discussed in detail. Advances in surgical techniques are highlighted. For metastatic disease, the molecular biology of kidney cancer is reviewed in a concise and understandable manner, including the data that has fostered novel targeted approaches that have revolutionized management. The several landmark phase III targeted therapy trials published in the last few years are placed in context with respect to current management.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Medicine.
Topical term or geographic name as entry element Oncology.
Topical term or geographic name as entry element Urology.
Topical term or geographic name as entry element Medicine & Public Health.
Topical term or geographic name as entry element Urology/Andrology.
Topical term or geographic name as entry element Oncology.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rini, Brian I.
Relator term editor.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
773 0# - HOST ITEM ENTRY
Title Springer eBooks
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Printed edition:
International Standard Book Number 9781627030618
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier http://dx.doi.org/10.1007/978-1-62703-062-5
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Item type E-Book
Copies
Price effective from Permanent location Date last seen Not for loan Date acquired Source of classification or shelving scheme Koha item type Damaged status Lost status Withdrawn status Current location Full call number
2014-04-07AUM Main Library2014-04-07 2014-04-07 E-Book   AUM Main Library616.6

Languages: 
English |
العربية